NeoGraph Analytics
Healthcare TechnologyNorth America20232032

Agentic AI In Healthcare Market Size, Share and Trends Analysis

The Agentic AI In Healthcare market was valued at $0.8 billion in 2023 and is projected to reach $15.5 billion by 2032 at a CAGR of 39%. This report analyzes market trends, growth drivers, and regional dynamics.

Revenue, 2023

$0.8B

Forecast, 2032

$15.5B

CAGR, 2024-2032

39%

Report Coverage

North America

Code: agentic-ai-in-healthcare-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Market Overview

The Agentic AI In Healthcare market is an emerging segment with significant growth potential, driven by advancements in AI technology and the need for efficient healthcare solutions. Valued at $0.8 billion in 2023, it is projected to reach $15.5 billion by 2032, growing at a CAGR of 39%.

Market Stage

Emerging

Adoption Level

Growing

Key Trends

Increasing adoption of AI in clinical workflowsFocus on autonomous drug discoveryRising investment in healthcare AI startupsIntegration of agentic AI with electronic health records
02

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 39%

Base Year (2023)

$1.1B

Forecast (2032)

$15.5B

CAGR (2024-2032)

39%

Market Share by Component
Market share distribution across 3 segments
Hardware15.0%

Physical devices that support the deployment of agentic AI systems, including specialized servers, GPUs, and edge computing devices for real-time processing.

Software70.0%

Core agentic AI platforms and applications that enable autonomous task execution, including natural language processing, decision-making algorithms, and integration tools.

Services15.0%

Professional services for implementation, customization, and ongoing support of agentic AI solutions, including consulting, training, and maintenance.

Regional Market Analysis
Market share and growth rate by region

North America

#1
Share: 45.0%CAGR: 42.0%

Largest market: United States

Europe

#2
Share: 28.0%CAGR: 38.0%

Largest market: Germany

03

Market Dynamics

  • Rising demand for efficient healthcare delivery
  • Increasing availability of healthcare data
  • Government initiatives promoting AI in healthcare
  • Advancements in natural language processing and machine learning
04

Market Segmentation

By Component
Market share distribution across 3 segments
Hardware15.0%

Physical devices that support the deployment of agentic AI systems, including specialized servers, GPUs, and edge computing devices for real-time processing.

Software70.0%

Core agentic AI platforms and applications that enable autonomous task execution, including natural language processing, decision-making algorithms, and integration tools.

Services15.0%

Professional services for implementation, customization, and ongoing support of agentic AI solutions, including consulting, training, and maintenance.

By Type

  • Task-specific Agents
  • General Agents
  • Multi-agent Systems

By Application

  • Drug Discovery
  • Clinical Trials
  • Patient Monitoring
  • Administrative Automation
  • Remote Patient Monitoring

By End User

  • Hospitals
  • Pharmaceutical Companies
  • Research Institutions
  • Other Healthcare Providers
05

Regional Analysis

1

North America

Lead: United States
CAGR: 42.0%Share: 45.0%

Dominates the market due to strong technological infrastructure, presence of major AI players, and early regulatory frameworks for AI-based medical devices.

2

Europe

Lead: Germany
CAGR: 38.0%Share: 28.0%

Driven by EU initiatives like the European Health Data Space and strong adoption in countries with advanced healthcare systems.

3

Asia Pacific

Lead: China
CAGR: 45.0%Share: 27.0%

Fastest-growing region fueled by government investments in digital health and large-scale healthcare digitization initiatives.

Country-Level Analysis

CountryShareGrowth
United States
35.0%
+42.0%
Germany
12.0%
+38.0%
Japan
10.0%
+45.0%
06

Competitive Landscape

I

IBM

United States

Leader110B

Developing Watson Health agentic AI for drug discovery, clinical decision support, and administrative automation.

Watson HealthWatson AI for Clinical Trials
M

Microsoft

United States

Leader200B

Leveraging Azure AI for healthcare to create agentic systems for patient monitoring, diagnostics, and research.

Azure AI for HealthcareMicrosoft Health Bot
N

NVIDIA

United States

Leader

Providing GPU-powered agentic AI solutions for medical imaging, drug discovery, and healthcare data analytics.

G

Google

United States

Challenger

Developing agentic AI models for medical imaging, diagnostics, and patient engagement through Google Health.

A

Anthropic

United States

Challenger

Focusing on safe and reliable agentic AI for healthcare applications, including clinical decision support.

T

Tempus

United States

Follower1.2B

Specializing in AI-driven precision medicine and agentic systems for clinical trials and patient data analysis.

Tempus LIMSTempus Clinical AI
07

Recent Developments

25
2025IBM

Announced the launch of Watson Health's agentic AI platform for clinical trial management, automating patient recruitment and protocol design.

25
2025Google

Deployed an agentic AI system for medical imaging analysis in partnership with a major hospital network, enabling real-time anomaly detection.

24
2024NVIDIA

Partnered with Mayo Clinic to develop an agentic AI solution for patient monitoring using NVIDIA's GPU infrastructure.

24
2024Anthropic

Released a new agentic AI model specifically designed for healthcare applications, focusing on safety and clinical reliability.

24
2024Microsoft

Integrated Azure AI with Epic EHR system to enable autonomous administrative task completion in hospitals.

08

Regulatory Landscape

FDA's Digital Health Pre-Cert Program for SaMDEU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR)HIPAA and GDPR for healthcare data privacy
09

Frequently Asked Questions

The market was valued at $0.8 billion in 2023 and is projected to reach $15.5 billion by 2032.
The compound annual growth rate (CAGR) for the market is estimated at 39% from 2024 to 2032.
North America currently dominates with approximately 45% market share, led by the United States.
Drug discovery and clinical trials management represent the fastest-growing applications, with a combined market share exceeding 40%.